Enaltec Labs Private Limited

Enaltec Labs Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN U21001MH2006PTC160020 Incorporated 24 February 2006 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2025
₹169.73 Cr
▲ 11% YoY
Net loss · FY 2025
₹58.54 Cr
Net margin -34.5%
EBITDA · FY 2025
-₹36.35 Cr
EBITDA margin -21.4%
Authorised capital
₹112 Cr
Registered with MCA
Paid-up capital
₹93.5 Cr
Issued & subscribed
Open charges
₹76.2 Cr
Satisfied ₹320.53 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
286
Provident fund records

About Enaltec Labs Private Limited

Data last updated:

Enaltec Labs Private Limited is a private limited company based in Thane, Maharashtra, India, a subsidiary of La Renon Healthcare Private Limited. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 24 February 2006 and has been in existence for over 20 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U21001MH2006PTC160020. Its GSTIN is 27AABCE5821H1ZS (Maharashtra). The company holds 3 GST registrations, all of them active.

The company has an authorised share capital of ₹112 Cr and a paid-up capital of ₹93.5 Cr. It is led by directors including Anand Prafulchandra Shah (Managing Director) and Bhavesh Bansidhar Pujara.

Its last annual general meeting (AGM) was held on 20 July 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Sector 19, Thane, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹169.73 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net loss of ₹58.54 Cr (net margin -34.5%) and EBITDA of -₹36.35 Cr (EBITDA margin -21.4%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 6% over five years.

The company has about 286 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Enaltec Labs. As per MCA filings, the company has open charges of ₹76.2 Cr and satisfied charges of ₹320.53 Cr on record. Court records list 26 cases involving the company, including 5 filed by the company and 21 filed against it; 2 cases are pending. The company has 14 deals on record (12 funding rounds, 2 secondary share transfers), with disclosed funding of ₹271.98 Cr; the latest was in January 2022. Its 9 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is GMFC Labs Private Limited with revenue of ₹179.23 Cr. The company has 15 MSME Form 1 returns on record between 2019 and 2024, listing 1,415 overdue payments to 146 micro and small suppliers.

Enaltec Labs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0018510). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website enaltec.com.

Company details

CIN U21001MH2006PTC160020
Registration Number 160020
Incorporation Date 24 February 2006
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 20 July 2026
Date of Balance Sheet 31 March 2026
Parent Company La Renon Healthcare Private Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-33-0018510

CIN history

Enaltec Labs has one previous CIN (Corporate Identification Number): U73100MH2006PTC160020. The current CIN is U21001MH2006PTC160020, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U21001MH2006PTC160020Current
U73100MH2006PTC160020Previous

Recognitions & Rankings of Enaltec Labs

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-MH-33-0018510

Contact details

Enaltec Labs Private Limited's registered office is in Thane, Maharashtra.

  • Social Media
  • Registered Address
    401 4th Floor Kesar Solitaire, Plot No 5 Sector 19 Sanpada Navi Mumbai, Thane, Maharashtra, India – 400705
  • Industry
    Pharma, API Manufacturers
Comprehensive company report
Enaltec Labs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Enaltec Labs operates one associated brand: Enaltec Labs. Each brand links to its own profile.

BrandDescriptionWebsite
Non-oncology APIs are developed and manufactured by Enaltec Labs.enaltec.com

Business activity

The main business activity of Enaltec Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Enaltec Labs Private Limited, buy the company report.

Financials of Enaltec Labs Private Limited

FY 2026 filings available

Enaltec Labs Private Limited reported revenue of ₹169.73 Cr (up 11% YoY) for FY 2025.

Revenue · FY 2025
₹169.73 Cr ▲ 11%
Net loss · FY 2025
₹58.54 Cr margin -34.5%
EBITDA · FY 2025
-₹36.35 Cr margin -21.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 7%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▼ 709%
3 years · compounded
▼ 165%
5 years · compounded
▼ 20%

Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 11% growth in the latest year. EBITDA fell 709% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹36.35 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹58.54 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-21.4%
Net Profit Margin-34.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Enaltec Labs Private Limited, buy the company report.

Board of directors of Enaltec Labs Private Limited

Enaltec Labs has 3 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Bhavesh Bansidhar PujaraNominee Director30 Dec 20250 Years 9 MonthsCurrent
Amish Vyas PravinchandraNominee Director20 Jun 20251 Years 4 MonthsCurrent
Anand Prafulchandra ShahManaging Director11 May 200719 Years 5 MonthsCurrent

Peer comparison

Enaltec Labs Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
GMFC Labs Private Limited₹179.23 Cr (FY 2025)106.0%Hyderabad, Telangana, India
Chandak Laboratories Private Limited₹178.82 Cr (FY 2024)-26.0%Hyderabad, Telangana, India
Mahima Lifesciences Private Limited₹177.98 Cr (FY 2025)-18.0%Delhi, India
Infinity Laboratories Private Limited₹176.27 Cr (FY 2025)-26.0%Derabassi, Punjab, India
Elppe Chemicals Private Limited₹173.94 Cr (FY 2024)8.0%Raigad, Maharashtra, India
Enaltec Labs Private Limitedthis company₹169.73 Cr (FY 2025)-₹58.54 Cr-34.5%11.0%Thane, Maharashtra, India
Mac-Chem Products (India) Private Limited₹167.51 Cr (FY 2025)6.0%Mumbai, Maharashtra, India
Vamsi Labs Limited₹167.4 Cr (FY 2025)28.0%North Solapur, Maharashtra, India
Srini Pharmaceuticals Private Limited₹165.56 Cr (FY 2024)-18.0%Hyderabad, Telangana, India
Chromo Laboratories India Private Limited₹164.91 Cr (FY 2025)-6.0%Patancheru, Telangana, India

To see the full peer comparison of Enaltec Labs Private Limited, buy the company report.

Charges & borrowings

Open charges
₹76.2 Cr
Satisfied charges
₹320.53 Cr
Breakdown by lending institutions
Others₹76.20 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
04 Sep 2025101157866Others₹60 CrOpen
04 Sep 2025101158294Others₹15 CrOpen
29 Sep 2023100799986Others₹1.2 CrOpen
30 Dec 2020100407081Axis Bank Limited₹4.93 CrSatisfied
20 May 2019100267190Others₹17.07 CrSatisfied

To see the full charge records of Enaltec Labs Private Limited, buy the company report.

Total charge records: 16 View all charges

Deals & funding

Enaltec Labs Private Limited has 14 deals on record (12 funding rounds, 2 secondary share transfers), with disclosed funding of ₹271.98 Cr; the latest was in January 2022.

Total deals
14
Funding rounds
12
Secondary share transfers
2
Disclosed funding
₹271.98 Cr

Deals on record (5 of 14)

WhenDealAmountParties
Jan 2022Funding round₹55 CrInvestors: La Renon Healthcare Private Limited , InvAscent
Feb 2020Funding round₹10 CrInvestors: an individual
Dec 2008Funding round₹81.6 LakhInvestors: Pharma Serv Ventures Private Limited
Jul 2007Funding round₹3.99 CrInvestors: Scitech Limited, Pharma Serv Ventures Private Limited , Medtech Limited
Sep 2006Secondary share transferUndisclosedBuyer: Pharma Serv Ventures Private Limited
Seller: 2 individuals

To see the full deal history of Enaltec Labs Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Enaltec Labs Private Limited was last rated by Crisil on 21 Oct 2020.

Rating agencyRated onRating
Crisil21 Oct 2020

To see the full credit ratings and regulatory alerts of Enaltec Labs Private Limited, buy the company report.

MSME payment delays

Enaltec Labs Private Limited has 15 MSME Form 1 returns on record between 2019 and 2024, listing 1,415 overdue payments to 146 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 146)

SupplierAmount dueDue sinceReported on
Nikita Chemical Industries CRS
an individual supplier
Av Processors Private Limited
an individual supplier
Sugen Life Sciences Private Limited

To see the full MSME payment records of Enaltec Labs Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Enaltec Labs has 3 GST registrations: 3 active.

Total GSTINs
3
Active
3
GSTINStateStatusRegistered on
27AABCE5821H1ZSMaharashtraActive01 Jul 2017
23AABCE5821H1Z0Madhya PradeshActive01 Jul 2017
29AABCE5821H1ZOKarnatakaActive01 Jul 2017

To see the full GST registrations and return filing status of Enaltec Labs Private Limited, buy the company report.

Recent activity

Enaltec Labs Private Limited has 19 board changes on record since 2007: 3 appointments and 16 cessations. The latest: Bhavesh Bansidhar Pujara was appointed as Nominee Director on 30 Dec 2025.

AGM
Enaltec Labs Private Limited last Annual general meeting of members was held on 20 Jul 2026 as per latest MCA records.
Filing
Enaltec Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai Ii.
Charges
A charge with Others of Rs. 60.00 Cr registered on 04 Sep 2025 with Charge ID 101157866 was modified on 02 Jan 2026.
Charges
A charge with Others of Rs. 15.00 Cr registered on 04 Sep 2025 with Charge ID 101158294 was modified on 02 Jan 2026.
Appointed
Bhavesh Bansidhar Pujara was appointed as Nominee Director.
Charges
A charge with Others amounted to Rs. 60.00 Cr with Charge ID 101157866 was registered on 04 Sep 2025.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101158294 was registered on 04 Sep 2025.
Charges
A charge registered on 02 Jan 2017 via Charge ID 100071385 with Axis Bank Limited was fully satisfied on 29 Jul 2025.
Charges
A charge registered on 24 Mar 2014 via Charge ID 10490646 with Others was fully satisfied on 29 Jul 2025.
Charges
A charge registered on 30 Dec 2020 via Charge ID 100407081 with Axis Bank Limited was fully satisfied on 18 Jul 2025.
Charges
A charge registered on 20 May 2019 via Charge ID 100267190 with Others was fully satisfied on 04 Jul 2025.
Appointed
Amish Vyas Pravinchandra was appointed as Nominee Director.

47 earlier events are in the company report.

Frequently asked questions

Enaltec Labs is an active private limited company based in Thane, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 24 February 2006 (20+ years old) and is registered under CIN U21001MH2006PTC160020.

Enaltec Labs has 3 current directors:

The latest financial statements of Enaltec Labs on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 20 July 2026. Year-wise statements from 2015 are in the company report.

The GSTIN of Enaltec Labs is 27AABCE5821H1ZS, registered in Maharashtra. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 23AABCE5821H1Z0 (Madhya Pradesh), 29AABCE5821H1ZO (Karnataka).

The CIN (Corporate Identification Number) of Enaltec Labs is U21001MH2006PTC160020. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Enaltec Labs has 26 court cases on record: 5 filed by the company and 21 filed against it. 2 are pending. Most are in the district courts.

Enaltec Labs was incorporated on 24 February 2006, making it 20+ years old. It is registered with the Registrar of Companies, Mumbai.

Enaltec Labs has 14 deals on record (12 funding rounds, 2 secondary share transfers), with disclosed funding of ₹271.98 Cr; the latest was in January 2022.

The peers of Enaltec Labs by revenue are GMFC Labs Private Limited, Chandak Laboratories Private Limited, Mahima Lifesciences Private Limited, Infinity Laboratories Private Limited, Elppe Chemicals Private Limited and 4 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Bhavesh Bansidhar Pujara was appointed as Nominee Director on 30 Dec 2025. Amish Vyas Pravinchandra was appointed as Nominee Director on 20 Jun 2025. Sumit Gupta ceased to be Nominee Director on 26 Oct 2024. Enaltec Labs has 19 board changes on record in total.

Yes, Enaltec Labs is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-33-0018510).

Enaltec Labs has 15 MSME Form 1 returns on record between 2019 and 2024, listing 1,415 overdue payments to 146 micro and small suppliers. The latest return was filed on 01 May 2024.